Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

Cynthia SungYuan WeiSatoru WatanabeHow Sung LeeYok Moi KhooLu FanAbhay P S RathoreKitti Wing-Ki ChanMilly M ChoyUma S KamarajOctober M SessionsPauline AwPaola F de SessionsBernett LeeJohn E ConnollyMartin L HibberdDhanasekaran VijaykrishnaLimin WijayaEng Eong OoiJenny Guek-Hong LowSubhash G Vasudevan

Published in: PLoS neglected tropical diseases (2016)

ClinicalTrials.gov NCT01619969.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
zika virus
prognostic factors
randomized controlled trial
hiv infected
clinical trial
double blind
dengue virus
patient reported outcomes
hiv infected patients